237 related articles for article (PubMed ID: 35030979)
1. Circular RNA hsa_circ_0032683 inhibits the progression of hepatocellular carcinoma by sponging microRNA-338-5p.
Shen H; Li H; Zhou J
Bioengineered; 2022 Feb; 13(2):2321-2335. PubMed ID: 35030979
[TBL] [Abstract][Full Text] [Related]
2. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
3. hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-1307.
Wang YG; Wang T; Ding M; Xiang SH; Shi M; Zhai B
Cancer Lett; 2019 Sep; 460():128-138. PubMed ID: 31207319
[TBL] [Abstract][Full Text] [Related]
4. Identification of the hsa_circ_0039466/miR-96-5p/FOXO1 regulatory network in hepatocellular carcinoma by whole-transcriptome analysis.
Yuan F; Tang Y; Cao M; Ren Y; Li Y; Yang G; Ou Q; Tustumi F; Levi Sandri GB; Raissi D; Pocha C; Deng M; Yao Z
Ann Transl Med; 2022 Jul; 10(14):769. PubMed ID: 35965793
[TBL] [Abstract][Full Text] [Related]
5. Hsa_circ_0079875 functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression.
Liu Y; Luo X; Chen W; Dong Z; Cheng T; Chen L; Ju L; Cai W; Bian Z
Cell Cycle; 2024 Mar; 23(5):519-536. PubMed ID: 38684479
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA hsa_circ_0006091 as a novel biomarker for hepatocellular carcinoma.
Zhang Y; Li J; Cui Q; Hu P; Hu S; Qian Y
Bioengineered; 2022 Feb; 13(2):1988-2003. PubMed ID: 35068348
[TBL] [Abstract][Full Text] [Related]
7. Identification of potentially functional circular RNAs hsa_circ_0070934 and hsa_circ_0004315 as prognostic factors of hepatocellular carcinoma by integrated bioinformatics analysis.
Morovat P; Morovat S; Ashrafi AM; Teimourian S
Sci Rep; 2022 Mar; 12(1):4933. PubMed ID: 35322101
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184.
Guo X; Wang Z; Deng X; Lu Y; Huang X; Lin J; Lan X; Su Q; Wang C
Cell Cycle; 2022 Aug; 21(15):1557-1577. PubMed ID: 35400275
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
Gong J; Du C; Sun N; Xiao X; Wu H
J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA hsa_circ_0003141 promotes tumorigenesis of hepatocellular carcinoma via a miR-1827/UBAP2 axis.
Wang Y; Gao R; Li J; Tang S; Li S; Tong Q; Mao Y
Aging (Albany NY); 2020 May; 12(10):9793-9806. PubMed ID: 32464601
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
Li X; Shen M
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
[TBL] [Abstract][Full Text] [Related]
13. Hsa_circ_0101432 promotes the development of hepatocellular carcinoma (HCC) by adsorbing miR-1258 and miR-622.
Zou H; Xu X; Luo L; Zhang Y; Luo L; Yao Y; Xiang G; Huang X; Wang G
Cell Cycle; 2019 Oct; 18(19):2398-2413. PubMed ID: 31095447
[TBL] [Abstract][Full Text] [Related]
14. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
[TBL] [Abstract][Full Text] [Related]
15. Circ-RNF13, as an oncogene, regulates malignant progression of HBV-associated hepatocellular carcinoma cells and HBV infection through ceRNA pathway of circ-RNF13/miR-424-5p/TGIF2.
Chen Y; Li S; Wei Y; Xu Z; Wu X
Bosn J Basic Med Sci; 2021 Oct; 21(5):555-568. PubMed ID: 33714261
[TBL] [Abstract][Full Text] [Related]
16. hsa_circ_102559 Acts as the Sponge of miR-130a-5p to Promote Hepatocellular Carcinoma Progression Through Regulation of ANXA2.
Li J; Yu Z; Zhu Q; Tao C; Xu Q
Cell Transplant; 2020; 29():963689720968748. PubMed ID: 33121269
[TBL] [Abstract][Full Text] [Related]
17. Hsa-circ-0000098 promotes the progression of hepatocellular carcinoma by regulation of miR-136-5p/MMP2 axis.
Cheng Y
Adv Clin Exp Med; 2023 Jun; 32(6):689-700. PubMed ID: 36881359
[TBL] [Abstract][Full Text] [Related]
18. Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3.
Zhang L; Zhang J; Li P; Li T; Zhou Z; Wu H
Cell Death Dis; 2022 Jan; 13(1):32. PubMed ID: 35013102
[TBL] [Abstract][Full Text] [Related]
19. Hsa_circ_0008092 Contributes to Cell Proliferation and Metastasis in Hepatocellular Carcinoma via the miR-502-5p/CCND1 Axis.
Maimaiti Y; Kamali A; Yang P; Zhong K; Abuduhadeer X
Protein Pept Lett; 2022; 29(7):595-604. PubMed ID: 35899951
[TBL] [Abstract][Full Text] [Related]
20. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
